A multi-omics study identifies causal genes and biological subtypes of long COVID, revealing new therapeutic targets for ...

A groundbreaking review in Biological Diversity proposes a proactive, AI - integrated approach to stop biological invasions ...

Multi-omics describes the integration of multiple high-throughput screening technologies based on genomics, proteomics, transcriptomics, single-cell transcriptomics, metabolomics, and more, which all ...

Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...

Efficacy of third-line and later (3L+) therapies post poly (ADP-ribose) polymerase inhibitor (PARPi) exposure in recurrent platinum-sensitive ovarian cancer (PSOC): A pooled clinical trial database ...

Long COVID, officially known as post-acute sequelae of SARS-CoV-2 infection (PASC), affects an estimated 10-20% of individuals who have contracted SARS-CoV-2. This condition can manifest with a range ...

Nearly 50 new cancer therapies are approved every year. While this positive trend is a huge benefit for patients, Altuna Akalin, PhD, head of the bioinformatics and omics data science technology ...

Acute myeloid leukaemia (AML) is mainly characterized by an increase in the number of myeloid cells in the bone marrow and a decrease in mature cells, accounting for 28% of leukaemia cases, with a ...

The Hong Kong University of Science and Technology (HKUST), in collaboration with the Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), has launched the world's first Deep ...

Shashank M. Patil has been awarded Ph.D in Life Sciences by the JSS Academy of Higher Education and Research (JSS AHER), for his thesis ‘Multi-omics Investigation of Bovine Colostrum Bioactive ...